Document is current
Any future updates will be listed below
-
Authors
Dricot, Caroline E.M.K.
Erreygers, Isabel
Cauwenberghs, Eline
De Paz, Jocelyn
Spacova, Irina https://orcid.org/0000-0003-0562-7489
Verhoeven, Veronique https://orcid.org/0000-0002-3708-6501
Ahannach, Sarah https://orcid.org/0000-0002-8274-5342
Lebeer, Sarah https://orcid.org/0000-0002-9400-6918
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 6 October 2024
First Online: 18 October 2024
Competing interests
: This review was written in the framework of the PhD research projects of C.D., I.E., and S.A. However, for transparency, the authors want to declare relationships and interests that could be perceived as a potential conflict of interest. This involves the patent application EP20210606.8 that has been submitted by the host institution (University of Antwerp) on findings related to microbially produced riboflavin in strain <i>Limosilactobacillus reuteri</i> AMBV339. S.L., I.S., and S.A. are listed as inventors. Moreover, the authors declare that they have received funding from different probiotic and food supplement companies to perform mechanistic and clinical research related to aspects discussed in this review.
